High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets-MedSci.cn

High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets

Wang, HW; Wang, XR; Xu, LP; Zhang, J; Cao, H

Wang, HW; Cao, H (corresponding author), Fujian Med Univ, Affiliated Hosp, Fujian Matern & Child Hlth Hosp, Fujian Key Lab Prenatal Diag & Birth Defect, Fuzhou, Fujian, Peoples R China.; Wang, HW; Cao, H (corresponding author), Natl Hlth & Family Planning Commiss, Key Lab Tech Evaluat Fertil Regulat Nonhuman Prim, Fuzhou, Fujian, Peoples R China.; Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai, Peoples R China.

Abstract

Reprogramming of metabolism is described in many types of cancer and is associated with the clinical outcomes. However, the prognostic significance of......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets

科室

工具

服务